+

WO2002040030A8 - Therapie combinee abaissant et regulant la tension intraoculaire - Google Patents

Therapie combinee abaissant et regulant la tension intraoculaire

Info

Publication number
WO2002040030A8
WO2002040030A8 PCT/US2000/031557 US0031557W WO0240030A8 WO 2002040030 A8 WO2002040030 A8 WO 2002040030A8 US 0031557 W US0031557 W US 0031557W WO 0240030 A8 WO0240030 A8 WO 0240030A8
Authority
WO
WIPO (PCT)
Prior art keywords
lowering
combination therapy
intraocular pressure
controlling intraocular
ocular hypertension
Prior art date
Application number
PCT/US2000/031557
Other languages
English (en)
Other versions
WO2002040030A1 (fr
Inventor
Abbot F Clark
Original Assignee
Alcon Lab Inc
Abbot F Clark
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc, Abbot F Clark filed Critical Alcon Lab Inc
Priority to AU2001217709A priority Critical patent/AU2001217709B2/en
Priority to AU1770901A priority patent/AU1770901A/xx
Priority to CA002428799A priority patent/CA2428799A1/fr
Priority to EP00980450A priority patent/EP1341541A4/fr
Priority to PCT/US2000/031557 priority patent/WO2002040030A1/fr
Priority to JP2002542403A priority patent/JP2004522711A/ja
Publication of WO2002040030A1 publication Critical patent/WO2002040030A1/fr
Publication of WO2002040030A8 publication Critical patent/WO2002040030A8/fr
Priority to AU2006200143A priority patent/AU2006200143B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention porte: sur une préparation ophtalmique combinant un angiostatique et un autre composé hypotenseur et traitant le glaucome et l'hypertension oculaire, et sur une méthode de traitement du glaucome et l'hypertension oculaire.
PCT/US2000/031557 2000-11-16 2000-11-16 Therapie combinee abaissant et regulant la tension intraoculaire WO2002040030A1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
AU2001217709A AU2001217709B2 (en) 2000-11-16 2000-11-16 Combination therapy for lowering and controlling intraocular pressure
AU1770901A AU1770901A (en) 2000-11-16 2000-11-16 Combination therapy for lowering and controlling intraocular pressure
CA002428799A CA2428799A1 (fr) 2000-11-16 2000-11-16 Therapie combinee abaissant et regulant la tension intraoculaire
EP00980450A EP1341541A4 (fr) 2000-11-16 2000-11-16 Therapie combinee abaissant et regulant la tension intraoculaire
PCT/US2000/031557 WO2002040030A1 (fr) 2000-11-16 2000-11-16 Therapie combinee abaissant et regulant la tension intraoculaire
JP2002542403A JP2004522711A (ja) 2000-11-16 2000-11-16 眼内圧の低下および制御のための組み合わせ治療
AU2006200143A AU2006200143B2 (en) 2000-11-16 2006-01-13 Combination therapy for lowering and controlling intraocular pressure

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/031557 WO2002040030A1 (fr) 2000-11-16 2000-11-16 Therapie combinee abaissant et regulant la tension intraoculaire

Publications (2)

Publication Number Publication Date
WO2002040030A1 WO2002040030A1 (fr) 2002-05-23
WO2002040030A8 true WO2002040030A8 (fr) 2002-11-07

Family

ID=21742004

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/031557 WO2002040030A1 (fr) 2000-11-16 2000-11-16 Therapie combinee abaissant et regulant la tension intraoculaire

Country Status (5)

Country Link
EP (1) EP1341541A4 (fr)
JP (1) JP2004522711A (fr)
AU (2) AU1770901A (fr)
CA (1) CA2428799A1 (fr)
WO (1) WO2002040030A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0316290D0 (en) 2003-07-11 2003-08-13 Glaxo Group Ltd Novel compounds
US7579335B2 (en) 2005-01-10 2009-08-25 Glaxo Group Limited Androstane 17α-carbonate derivatives for use in the treatment of allergic and inflammatory conditions
TW201010727A (en) * 2008-09-03 2010-03-16 Alcon Res Ltd Pharmaceutical composition having relatively low ionic strength
EP3006453A1 (fr) 2014-10-08 2016-04-13 Cosmo Technologies Ltd. 17alpha-monoesters et 17alpha, 21-diesters de cortexolone pour utilisation dans le traitement de tumeurs
CN108066283B (zh) * 2017-12-28 2020-03-24 兆科（广州）眼科药物有限公司 一种盐酸左倍他洛尔滴眼液的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
WO1987007141A1 (fr) * 1986-05-23 1987-12-03 New England Medical Center Hospitals, Inc. Methode de traitement du glaucome
US4904649A (en) * 1986-05-23 1990-02-27 New England Medical Center Hospitals, Inc. Method and solution for treating glaucoma
US4876250A (en) * 1988-10-31 1989-10-24 Alcon Laboratories, Inc. Methods for controlling ocular hypertension with angiostatic steroids
US5371078A (en) * 1988-10-31 1994-12-06 Alcon Laboratories, Inc. Angiostatic steroids and methods and compositions for controlling ocular hypertension
US5153192A (en) * 1990-04-09 1992-10-06 Alcon Laboratories, Inc. Thiophene sulfonamides useful as carbonic anhydrase inhibitors
US5153193A (en) * 1991-10-01 1992-10-06 Hoechst-Roussel Pharmaceuticals Incorporated Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs
ES2187503T3 (es) * 1991-11-22 2003-06-16 Alcon Lab Inc Esteroides angiostaticos.
US5540930A (en) * 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
EP1069913B1 (fr) * 1998-04-07 2003-07-23 Alcon Laboratories, Inc. Compositions ophtalmiques gelifiantes, contenant de la gomme de xanthanne
BR9913955A (pt) * 1998-09-25 2001-06-12 Alcon Lab Inc Composição oftalmológica confortável e de liberação sustentada e método para terapia ocular

Also Published As

Publication number Publication date
EP1341541A4 (fr) 2004-11-17
AU2001217709B2 (en) 2005-10-13
AU1770901A (en) 2002-05-27
CA2428799A1 (fr) 2002-05-23
EP1341541A1 (fr) 2003-09-10
WO2002040030A1 (fr) 2002-05-23
JP2004522711A (ja) 2004-07-29

Similar Documents

Publication Publication Date Title
AU2003274734A1 (en) Method and composition containing latanoprost for treating ocular hypertension and glaucoma
MX9702349A (es) Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma.
CA2440764A1 (fr) Combinaison de brimonidine et de timolol pour utilisation topique ophtalmique
WO2006071548A3 (fr) Analogues d'aminopyrazine servant a traiter le glaucome et d'autres maladies ou etats medies par rho kinase
WO2002062385A3 (fr) Methode de prevention de la perte de la vue
WO2007076360A8 (fr) (indazol-5-yl)-pyrazines et (1,3-dihydro-indol-2-un)- pyrazines pour le traitement de maladies et de conditions a mediation de rho kinase
EP1514548A3 (fr) Utilisation du cloprstenol, fluprostenol et analogues pour le traitement du glaucome et de l' hypertension intraoculaire
CA2315829A1 (fr) Agents angiostatiques et compositions permettant de lutter contre l'hypertension intra-oculaire
WO2005002520A3 (fr) Compositions ophtalmiques destinees au traitement d'hypertension oculaire
WO2006066103A3 (fr) Implant ophtalmique pour traitement du glaucome
WO2003047513A3 (fr) Methode de traitement de l'hypertension oculaire
BR0210241A (pt) Piranoindazóis e seu uso no tratamento de glaucoma
WO2003072066A3 (fr) Compositions et methode de traitement du glaucome et de l'hypertension oculaire
WO2002009702A8 (fr) Methode de reduction de la pression intraoculaire avec des derives d'indole
WO1998039293A3 (fr) 13-thia prostaglandines destinees a etre utilisees dans la therapie du glaucome
WO2000018316A3 (fr) Composition ophtalmique agreable, a liberation prolongee, et procede de therapie oculaire
WO2001068053A3 (fr) Procedes et compositions pour traiter et prevenir des affections ophtalmiques de la partie posterieure de l'oeil
CA2582316A1 (fr) Utilisation d'inhibiteurs de jun n-terminal kinases pour le traitement de la retinopathie glaucomateuse et de maladies oculaires
CA2505086A1 (fr) Compositions ophtalmiques pour le traitement de l'hypertension oculaire
WO2005020917A3 (fr) Compositions ophtalmiques pour le traitement de l'hypertension oculaire
WO2004043354A3 (fr) Compositions ophtalmiques pour traiter l'hypertension oculaire
WO2002040030A8 (fr) Therapie combinee abaissant et regulant la tension intraoculaire
AU687906B2 (en) Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
WO2001070207A3 (fr) Agonistes de 5ht2 permettant de commander la pression intra-oculaire elevee et de traiter le glaucome
EP1251862A4 (fr) Compositions ophthalmiques pour traiter l'hypertension oculaire

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU BR CA CN JP MX PL ZA

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: C1

Designated state(s): AU BR CA CN JP KR MX PL US ZA

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

WWE Wipo information: entry into national phase

Ref document number: 2001217709

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2002542403

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2000980450

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2428799

Country of ref document: CA

WWP Wipo information: published in national office

Ref document number: 2000980450

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 2001217709

Country of ref document: AU

WWR Wipo information: refused in national office

Ref document number: 2000980450

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2000980450

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载